Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis
- 1 June 2001
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 34 (6) , 903-910
- https://doi.org/10.1016/s0168-8278(01)00080-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantationLiver Transplantation and Surgery, 1999
- High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantationJournal of Hepatology, 1999
- Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulinHepatology, 1998
- Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis†Hepatology, 1998
- PRETRANSPLANT FAMCICLOVIR AS PROPHYLAXIS FOR HEPATITIS B VIRUS RECURRENCE AFTER LIVER TRANSPLANTATIONTransplantation, 1997
- Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosisThe Lancet, 1996
- Hepatitis B Virus Envelope Variation After Transplantation With and Without Hepatitis B Immune Globulin ProphylaxisHepatology, 1996
- Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipientsJournal of Hepatology, 1994
- Liver Transplantation in European Patients with the Hepatitis B Surface AntigenNew England Journal of Medicine, 1993
- Passive immunoprophylaxis after liver transplantation in HBsAg-positive patientsThe Lancet, 1991